Clinical Trials Browser

Phase 2 × Carcinoma, Ovarian Epithelial × Bevacizumab × Clear all

NCT06890338 2026-02-24

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Phase 2 Recruiting

140 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT03093155 2024-05-14

Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab

Phase 2 Completed

78 enrolled 18 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT04015739 2022-08-17

BOLD

Phase 2 Unknown

74 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Recurrence

NCT05158062 2022-04-26

Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer

Phase 2 Unknown

35 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01551745 2021-10-19

Salvage Ovarian FANG™ Vaccine + Bevacizumab

Phase 2 Completed

5 enrolled 9 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01146795 2021-02-09

Neoadjuvant Therapy for Ovarian Cancer

Phase 2 Completed

32 enrolled 10 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT02022917 2021-01-27

Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian Cancer

Phase 2 Completed

22 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00022659 2019-07-24

Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Phase 2 Completed

64 enrolled 11 charts

Gynecologic

Carcinoma, Ovarian Epithelial

NCT00583622 2013-05-21

Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients

Phase 2 Terminated

13 enrolled 5 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00407563 2012-04-05

Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer

Phase 2 Completed

48 enrolled 11 charts

Gynecologic

Carcinoma, Ovarian Epithelial